Xencor
XNCR
122 hedge funds and large institutions have $1.34B invested in Xencor in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 12 closing their positions.
158% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 12
64% more capital invested
Capital invested by funds: $819M → $1.34B (+$521M)
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
16% more funds holding
Funds holding: 105 → 122 (+17)
2.78% more ownership
Funds ownership: 79.58% → 82.35% (+2.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$48.5M |
| 2 |
Primecap Management
Pasadena,
California
|
+$34.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.8M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$23.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$10.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$5.78M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.73M |
| 4 |
Renaissance Technologies
New York
|
-$2.63M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.48M |
XNCR Hedge Fund Activity: Q1 2018 in Review
122 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Xencor (XNCR) for Q1 2018, worth a combined $1.34B — up 64% from $819M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new XNCR positions and 12 closed out — a net gain of 19 holders — while 40 added to existing stakes and 34 trimmed.
The largest buyer was Redmile Group, adding an estimated $48.5M. The largest seller was OrbiMed, cutting an estimated $10.7M.
- 122 institutional investors held Xencor (XNCR) as of Q1 2018, up from 105 in Q4 2017.
- Funds reported $1.34B of Xencor stock for Q1 2018, up 64% quarter-over-quarter.
- 31 funds opened new Xencor positions in Q1 2018 and 12 closed out, a net change of +19 holders.
- The largest Xencor buyer in Q1 2018 was Redmile Group, an estimated $48.5M added.
- The largest Xencor seller in Q1 2018 was OrbiMed, an estimated $10.7M sold.
Based on aggregated 13F filings for Q1 2018.